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The purpose is to assess the characteristics of echovariation in amyotrophic lateral 3 
sclerosis (ALS) compared with other MUS parameters. Twenty-six ALS patients (8 4 
women, mean age 58.9 years, SD 12.02 yr) and 26 healthy controls (17 women; mean age 5 
59.6 years, SD 6.41 yr) were included in this observational study. They underwent 6 
bilateral and transverse ultrasound of the biceps/brachialis, forearm flexor group, 7 
quadriceps femoris and tibialis anterior. Muscular thickness, echointensity and 8 
echovariation were analyzed. Muscles affected by ALS showed increased echointensity, 9 
decrease in thickness, and decrease echovariation. Echovariation in all muscles but 10 
quadriceps femoris, strongly correlated with muscle strength (explained variance between 11 
21.8% in the biceps/brachialis and 37.5% in tibialis anterior) and the ALSFRS- R score 12 
(explained variance between 26% in the biceps/brachialis and 36.7% in the forearm flexor 13 
group). Echovariation is an easy to obtain QMUS parameter that could distinguish ALS 14 
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Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative 3
disease involving the upper and lower motor neuron (LMN) that produces muscle 4
fasciculations, weakness and atrophy. Clinical monitoring of LMN is usually based on 5
testing muscular strength with the Medical Research Council scale (MRC) (Florence et 6
al. 1992) and the revised ALS functional rating scale, (ALSFRS-R) (Cedarbaum et al. 7
1999). However, these tools show limited sensitivity for measuring changes and, 8
consequently, clinical endpoints usually require prolonged follow up (Simon et al. 2014; 9
Turner and Benatar 2015). In clinical trials, therefore, reliable biomarkers measurable 10
over the short term are desirable (Turner and Benatar 2015). 11
Although several neurophysiological tools have been developed as progression 12
biomarkers in ALS (Simon et al. 2014), they require wide operator experience, are time 13
consuming and pain is a considerable limiting factor (Simon et al. 2014). 14
Current ALS diagnostic criteria require the detection by electromyography (EMG) 15
of denervation signs or fasciculations in muscles with neurogenic changes (Costa et al. 16
2012). A fasciculation is an involuntary synchronous contraction of all the skeletal 17
muscle fibers within a single motor unit, which arises as a result of spontaneous 18
depolarization of a lower motor neuron. Fasciculation potentials of abnormal morphology 19
in the EMG recording are a characteristic clinical feature of ALS, but fasciculation 20
potentials of normal morphology can occur in healthy subjects (Brooks et al. 2000).  21
Muscle ultrasonography (MUS) is an accessible, painless and easy to perform 22
method to detect fasciculations and structural muscle changes in ALS (Arts et al. 2011a; 23
Simon et al. 2014). MUS has been shown more sensitive than EMG for detecting 24
fasciculations, especially in the bulbar region (Grimm et al. 2015; Misawa et al. 2011) 25
and structural changes such as decrease of muscle thickness and increase of echointensity 26
(EI) have been found (Arts et al. 2011a; Misawa et al. 2011; Simon et al. 2014). 27
4  
However, their role as diagnostic or progression biomarkers is limited, because of the 1 
high interindividual variability in structural parameters (Arts et al. 2011a; Misawa et al. 2 
2011; Pillen et al. 2008). Therefore, it would be a major advance to find a MUS 3 
biomarker not influenced by other factors than disease ones. Echovariation (EV) has been 4 
previously established to characterize plantar fasciitis and it is a reproducible, short and 5 
easy to carry out procedure (Ríos-Díaz et al. 2015). 6 
We hypothesize that EV could act as a more reliable biomarker in ALS since it is 7 
an adimensional parameter (Arts et al. 2011a). Therefore, we compared muscle thickness, 8 
EI and EV in four muscle groups in ALS patients and age matched controls and assessed 9 
how time and other clinical variables influenced these parameters. 10 
 11 
 12 
MATERIAL AND METHOD 13 
 14 
Subjects selection 15 
 16 
Patients (n=26) were recruited from the Valencia ALS Association (ADELA) 17 
between September 2013 and April 2014. The patients were diagnosed as having ALS by 18 
an experienced neurologist (JFVC), according to the revised El Escorial Criteria (Brooks 19 
et al. 2000). 20 
Twenty-six healthy volunteers without a history of hereditary neuromuscular 21 
disease were recruited as control group. 22 
 23 
 24 
Standard protocol approvals, registrations, and patient consents 25 
 26 
This study was approved by the ethics committee of the Universidad Católica de 27 
Murcia (Spain) and performed following the Helsinki Declaration principles. All 28 
participants provided written informed consent. 29 
 30 
 31 
Recorded clinical variables 32 
 33 
5  
Demographical and clinical characteristics (sex, age, weight, height, body mass 1 
index -BMI-, time of evolution from symptoms onset and date of diagnosis) were 2 
recorded. ALSFRS-R score (Cartwright et al. 2011) and muscle strength, measured with 3 
the Medical Research Council (MRC) rating scale (Arts et al. 2011a), were assessed by 4 




MUS was performed in four muscle groups of each side in patients and controls 9 
by the same experienced examiner (JMP) with the participants sitting and completely 10 
relaxed. A LEbt12 phased array real-time scanner (software 2014) from General Electric 11 
Company with a 513 MHz linear array transducer (12LRS) was used for MUS. All 12 
system-setting parameters, such as gain (98 dB), time gain compensation (in neutral 13 
position), depth (5 cm for tibialis anterior and 6 cm for the other muscle groups), 14 
frequency (12 Mhz), compression and focus (two focal points at 1.8 and 2.6 cm) were 15 
kept constant throughout the study. 16 
To avoid oblique scanning angles the angle of the probe was adjusted until the 17 
best muscle EI was obtained in every image. 18 
Applying the standardized protocol described by Arts et al. (2008) bilateral 19 
transverse ultrasound images of the biceps/brachialis group (2/3 distance acromion  20 
antecubital crease), forearm flexors group (2/5 distance antecubital crease distal end 21 
radius), quadriceps (1/2 distance anterior superior iliac spine superior aspect patella) 22 
and tibialis anterior (1/4 distance inferior aspect patella lateral malleolus) were obtained 23 
and measured. Three images were taken of every muscle in order to minimize variation in 24 
muscle thickness, EI and EV. 25 
The resulting bitmaps had a resolution of 820 x 614 pixels (7.6 px/mm) with 256 26 





Image analysis 4 
 5 
Fasciculations as well as quantitative MUS variables (QMUS), including muscle 6 
thickness, EI and EV, were obtained for each muscle group. 7 
Muscle thickness was measured with electronic calipers as previously described 8 
(Arts et al. 2010). The thickness of the biceps/brachialis group was measured between the 9 
uppermost part of the bone echo of the humerus and the superficial fascia of the biceps; 10 
the forearm flexor group between the interosseous membrane (next to the radius) and the 11 
superficial fascia of the most ventral flexors; the quadriceps femoris between the 12 
uppermost part of the bone echo of the femur and the superficial fascia of the rectus 13 
femoris (which includes the vastus intermedius); and the tibialis anterior between the 14 
interosseous membrane (next to the tibia) and the ventral fascia of the tibialis anterior 15 
(Figure 1). 16 
Fasciculations were registered in each muscle for 10 seconds as previously 17 
published (Arts et al. 2008). 18 
Thickness was measured in all three images of each muscle group by an expert 19 
ultrasonographist (JMP) and the mean of the three values was used for the corresponding 20 
analysis. 21 
Image processing and analysis was performed by one researcher (JRD) using the 22 
ImageJ (v.1.48) software. This researcher, who was blind for diagnosis, selected the 23 
region of interest (ROI) the ROI Manager application for ImageJ, with a size of 71 x 40 24 
pixels for tibialis anterior and 73 x 73 pixels for other muscle groups on an 8-bit gray 25 
scale. The ROI was defined as the muscle region without bone and fascia with the best 26 
reflection (Figure 1).  27 
EV, a parameter that can be interpreted as a measure of intensity range (Ríos-28 
7  
Díaz et al. 2015), was determined by the relation between standard deviation and mean of 1 
pixel intensity obtained from the histogram: 2 
EV         3 
 4 
where σ is the standard deviation of the image intensities and μ is the mean value of 5 
intensity in each ROI. 6 
EI and EV were obtained from the ROIs of three images of each muscle and the 7 
mean of the three values was used for analysis. Sets of 20 images for each muscular 8 
group were analyzed by another researcher (MEDBA) who was blinded to the previous 9 
results to analyze inter-observer reliability in thickness measurement and ROI selection. 10 




Data were analyzed using IBM SPSS Statistics for Windows 19.0 (IBM 15 
Company, 2010). 16 
Variables were checked for normality by the Kolmogorov-Smirnov test and for 17 
the homogeneity of variances by the Levene test. In addition, we analyzed the asymmetry 18 
and kurtosis coefficients and the normality Q-Q plots. 19 
Data were summarized as mean and standard deviations (SD), with 95% 20 
confidence intervals (CI) for continuous variables, and absolute and relative frequencies 21 
for categorical variables. 22 
Intraclass correlation coefficient (ICC) for 2-way mixed effect model and absolute 23 
agreement was calculated to determine inter-observer reliability of thickness measure, EI 24 
and EV. Next criteria were used to judge the reliability coefficients: very low (<0.20), 25 
low (0.21-0.40), moderate (0.41-0.60), good (0.61-0.80) and very good (0.81-1.00). 26 
Unpaired t-tests were used to compare continuous variables and chi- square test to 27 
compare categorical variables at baseline between ALS patients and controls.  28 
Paired t-tests were used to assess right-left differences in muscle thickness, EI and 29 
8  
EV measurements (Armitage et al. 2002). 1 
 2 
QMUS variables in patients and controls 3 
 4 
One-way ANCOVA was used to compare QMUS variables in patients and 5 
controls, controlling for effects of clinical and demographical covariates (Feinstein 2002) 6 
Cohen’s d statistic was used to evaluate the effect sizes, in this case by dividing 7 
mean score differences between patient and control group by the initial standard deviation 8 
of the control group (Cohen 1988; Kelley and Preacher 2012). A Cohen’s d statistic of 9 
<0.1 corresponds to a small size effect, around 0.3 to a medium size effect and > 0.5 a 10 
large size effect. 11 
Influence of time of evolution. 12 
 13 
Regression models were used to study the relationship between time of evolution 14 
(logarithmic transform was applied to this variable to correct the absence of a normal 15 
distribution) as independent variable and the QMUS parameters as dependent variables 16 
(Kleinbaum et al. 1998). 17 
Relations between QMUS parameters and MRC- ALSFRS-R 18 
 19 
MRC and ALSFRS-R were taken as dependent variables to check the relationship 20 
with QMUS parameters (thickness, echointensity and echovariation as independent 21 
variables). 22 
All regressions were carried out with a fixed inclusion of ultrasonographics 23 
parameters to obtain a raw model and the stepwise inclusion of sex, age, and BMI. The P-24 
in and P-out values were 0.05 and 0.10, respectively. To control for possible collinearity, 25 
the tolerance to enter in the model was fixed at 0.01 (Hair et al. 2010). 26 
The presence of influential observations was checked with the Cook distance (any 27 
influential observation was considered a Cook distance of >1). Collinearity for 28 
independent variables was evaluated with the tolerance and variance inflation factors 29 
(Kleinbaum et al. 1998). Data are presented as b coefficient and 95% CI. The relation 30 
9  
between variables was studied with a partial correlation coefficient that adjusts the linear 1 
relation between the dependent and independent variables. In addition, we calculated the 2 
goodness of fit with the partial determination coefficient (r-squared in %). 3 





Study subjects characteristics 9 
 10 
Twenty-six participants with ALS (8 women, mean age 58.9 years, SD 12.02 yr) 11 
and 26 healthy controls (17 women; mean age 59.6 years, SD 6.41 yr) were included in 12 
this study. No significant differences in age, height and weight were found. BMI was 13 
slightly different and sex distribution was significantly different. The clinical 14 
characteristics along with their mean and standard deviation (SD) are shown in Table 1. 15 
 16 
 17 
Ultrasound variables 18 
 19 
Fasciculations were detected in 15 of the 26 patients (57.7%) and none of the 20 
healthy controls. Altogether, they were detected in 30 out of 52 (57.7%) of the 21 
biceps/brachialis group, 26 (50%) of the forearm flexor group, 22 (42.3%) of the 22 
quadriceps femoris and 13 (25.7%) of tibialis anterior. 23 
QMUS variables for each muscle and group are shown in Table 2. There were no 24 
significant right–left differences in thickness, EI or EV in the four studied muscle groups, 25 
so only one sample of each right/left muscle group was selected for further analysis (52 26 
ultrasonograms for each group). 27 
The inter-observer reliability ICCs for thickness measurement were over 0.97 for 28 
all the muscular groups that revealed a very good reliability. Inter-observer measures of 29 
echointensity revealed very good reliability too; the highest ICC was obtained for 30 
quadriceps femoris (ICC=0.98; 95% CI= 0.95 to 0.99) and the lowest for tibialis anterior 31 
(ICC=0.95; 95% CI= 0.87 to 0.98). As regards the reliability of echovariation, the inter-32 
10  
observer ICCs were over 0.80 for all the muscular groups. 1 
When analyzing QMUS differences between patients and controls, mean 2 
comparisons were made with the corresponding corrections for sex and BMI (see 3 
footnotes in tables for details). As expected, muscle thickness in the ALS group was 4 
significantly lower than in the healthy controls for all analyzed muscles groups. EI was 5 
higher in patients than in controls, except in the case of quadriceps femoris where no 6 
differences between patients and controls were found. Finally, EV was significantly 7 
lower in patients for all muscles, with a strong size effect (higher than 1.0), except for 8 
quadriceps femoris which showed a moderate size effect of 0.55. 9 
 10 
Relation between QMUS parameters and time from symptoms onset. 11 
 12 
Table 3 shows the results of the raw and adjusted regression analysis for age, sex 13 
and BMI, when necessary. 14 
No significant relationship was found between time of evolution and QMUS for 15 
any muscle group, although in the biceps/brachialis group a 6.71% of the EV variance 16 
could be explained by time of evolution, which was nearly significant. 17 
BMI, age and sex showed an interaction with muscle thickness and EI, but not 18 
with EV. 19 
 20 
Relation between QMUS parameters and MRC-ALFSRS-R 21 
 22 
Table 4 shows the relationships between the QMUS parameters and MRC ad 23 
ALFSRS-R scores. Correlations are expressed as partial correlations, which provide 24 
information on the explained variance about the individual variable without the effect of 25 
the others. 26 
A significant and positive relationship was found between thickness and EV, and 27 
the MRC score in all regions, i.e. the greater the thickness or EV the higher the MRC 28 
score. The explained variance for thickness was between 24.8% in the biceps/brachialis 29 
11  
group and 7.4% in the forearm flexor group. The explained variance for EV was between 1 
26.5% in the tibialis anterior and 4.5% in the quadriceps femoris. The EI showed no 2 
significant correlation with MRC in any muscular group. 3 
Analysis of the relationship between the ALSFRS-R score and QMUS parameters 4 
showed similar results. Thickness and EV were significantly and directly correlated with 5 
the ALSFRS-R score: the greater the thickness or EV the higher the ALSFRS-R score. 6 
The explained variance for thickness was between 26.9% in the biceps/brachialis group 7 
and 7.5% in the forearm flexor group. The explained variance for EV was between 36.7% 8 
in the forearm flexor group and 8.9% in the quadriceps femoris. 9 
The EI showed an inverse correlation with the ALSFRS-R score only in tibialis 10 





We describe a new QMUS parameter (EV) that could be useful as diagnostic 16 
and/or progression biomarker in ALS, and compared its characteristics with those of 17 
previously described QMUS parameters (muscle thickness and EI). 18 
Previous studies have shown that muscle thickness decreases and EI increases 19 
even in clinically unaffected muscles (Arts et al. 2011a; Arts et al. 2012; Grimm et al. 20 
2015), reflecting the progressive muscular atrophy and fibrosis that occurs in ALS as a 21 
result of muscle denervation (Pillen et al. 2009). Recently, MUS has been proposed to 22 
increase the sensitivity of EMG if both the presence of fasciculations and EI are taken 23 
into account (Arts et al. 2012; Grimm et al. 2015), suggesting their role as diagnostic 24 
biomarker. However, EMG remains necessary for ALS diagnosis, since decreased muscle 25 
thickness and increased EI are age-dependent, show high interindividual variability, and 26 
can also be observed in other neuromuscular diseases (Pillen et al. 2008). 27 
The major advantage of MUS is that it is a painless technique. Consequently, its 28 
12  
role in monitoring progression in clinical trials could be of great value to avoid the 1 
repetition of painful techniques such as EMG. However, correlation between EI and 2 
muscle thickness and muscle strength and disability is only weak (Arts et al. 2011a; 3 
Grimm et al. 2015) and disease progression measured as changes in MRC or ALSFRS- R 4 
does not correlate with any of them (Arts et al. 2011a). The ultimate cause of this remains 5 
unknown but suggests that factors other than disease related ones could influence changes 6 
in EI or muscle thickness. Another reason may be that the reproducibility of these 7 
measurement techniques is limited because of the ROI selection or because very 8 
important adjustments such as frequency and depth of ultrasonography are not taken into 9 
account or two different US devices are used (Arts et al. 2011b; Florence et al. 1992; 10 
Pillen et al. 2009). Whatever the reason, it implies a strong limitation and a major 11 
challenge of MUS when used as a progression biomarker. 12 
Second order statistical methods of texture analysis have also been proposed to improve 13 
accuracy and precision of these measures (Molinari et al. 2015). However, in comparison 14 
to EI or muscle thickness they require more complex post-processing operations. 15 
Consequently, reproducibility supposes a strong limitation and a major challenge 16 
of MUS when used as a progression biomarker. To minimize this risk, we performed all 17 
studies with the same US device, we strictly defined the acquisition parameter and the 18 
mean of three images of each muscle was calculated for each parameter. Moreover, the 19 
inter-observer reliability in ROI selection for EI and EV and thickness measure were vey 20 





As expected, MUS identified frequent and widespread fasciculations. However, 26 
they were less frequent than previously reported (Grimm et al. 2015; Misawa et al. 2011), 27 
especially in lower limbs. Most patients in our study had lower limb onset and were at a 28 
13  
moderate to advanced stage of the disease. Fasciculations are an early finding in ALS and 1 
their frequency diminishes with time (de Carvalho and Swash 2013), which might explain 2 




Muscle thickness 7 
 8 
As described in previous studies (Arts et al. 2008; Arts et al. 2012; Grimm et al. 9 
2015), a decrease in muscle thickness was observed in ALS patients compared to healthy 10 
controls. The highest size effect of this difference was obtained for quadriceps femoris. 11 
As mentioned above, this finding could be related to the fact that in more than 50% of 12 
subjects with ALS in our sample, symptoms started in lower limbs. 13 
As previously published, muscle strength and disability showed a weak 14 
correlation with muscle thickness (Arts et al. 2011a) except for the quadriceps femoris 15 
where this correlation was moderate. No clear correlation was found between EV and 16 





EI can be estimated using either a subjective visual grading scale (Grimm et al. 22 
2015) or a quantitative methodology with an average gray-scale analysis that provides 23 
more objective and potentially more sensitive information, but which does not contain 24 
any data about tissue homogeneity (Pillen et al. 2008). Quantitative analysis of the EI is 25 
dependent on settings, the ultrasound device and on ROI selection, so that to record EI, a 26 
standardized protocol and some degree of experience are necessary. New methods of 27 
computer-assisted texture analysis, such as gray level co-occurrence matrix (Pillen et al. 28 
2008; Ríos-Díaz et al. 2010) and fractal analysis (Gdynia et al. 2009), have been proposed 29 
to quantify muscle alterations in neuromuscular disorders. However, these procedures 30 
14  
require expert handling of image analysis software and involve extra time for exportation 1 
and subsequent computer analysis, which could hinder their application in clinical 2 
practice. 3 
In the present study we analyzed EI using the Arts protocol (Arts et al. 2008), but 4 
system-setting parameters such as frequency, gain, compression, time gain compensation, 5 
focus (number and position) and depth were kept constant throughout our study to ensure 6 
measurement reliability (Mayans et al. 2012). As suggested by Gdynia et al. (2009), we 7 
selected a small ROI, unlike other authors who selected the largest ROI possible (Arts et 8 
al. 2008; Arts et al. 2011a; Arts et al. 2011b). In this last approach, large muscle areas are 9 
evaluated, combining areas of maximum reflection with anisotropic areas, which cause a 10 
decrease in EI. In our study, a ROI of the most reflective muscle segment, avoiding 11 
anisotropic muscle areas was obtained. This ensures that zones are selected in which 12 
muscle tissue presents maximum brightness. 13 
EI was found to increase in all the muscles studied of ALS patients except, 14 
intriguingly, the quadriceps femoris. Considering that symptoms in most patients started 15 
in the lower limbs and that EI significantly interacted with sex, age and BMI, we suggest 16 
that EI (at least in quadriceps femoris) can be influenced by non-disease related factors, 17 
limiting its usefulness. Moreover, as previously reported (Grimm et al. 2015), we found 18 
no significant correlation between EI and time of evolution. Likewise, no correlation was 19 
found with muscle strength or disability. Others have found a weak correlation with these 20 
variables (Arts et al. 2011a; Grimm et al. 2015); however, our statistical analysis (partial 21 




We propose a new MUS biomarker, EV, which is a first order statistical measure 26 
that quantifies the deviation of the level of gray from the average. It is a fast and easy 27 
method to obtain information on tissue homogeneity (Aggarwal and Agrawal 2012) and 28 
15  
an adimensional parameter, reducing the chance of the heterogeneity. 1 
In our study, we observed a significantly lower level of EV in the muscles of ALS 2 
patients compared to healthy controls, with higher effect sizes than those found for 3 
muscle thickness or EI except for the quadriceps femoris, in which muscle thickness 4 
showed greater effect. Unlike EI, EV did not interacted with non-disease related factors 5 
such as age, sex or BMI, further suggesting its potential as biomarker. Moreover, muscle 6 
strength and disability strongly correlated with EV except, once again, for the quadriceps 7 
femoris. Conversely, no clear correlation was found between EV and disease duration. 8 
There are some limitations in our study. First, the study is transversal and the 9 
number of studied subjects was limited. Moreover, our cohort of ALS patients was in a 10 
moderate to advanced disease stage and no ALS mimics subjects were studied. Therefore, 11 
in order to establish the role of EV as a diagnostic, progression or prognostic biomarker, 12 
these results must be replicated in a larger, prospective and longitudinal cohort of 13 
suspected ALS patients. 14 
In conclusion, we describe a new, easy to obtain QMUS parameter that seems to 15 
distinguish ALS from healthy controls more accurately than previous described 16 
biomarkers. It also seems to correlate better with strength and disability, limiting the 17 
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FIGURE LEGENDS 1 
 2 
Figure 1. The ultrasound measurement of echointensity and muscle thickness. 3 
Ultrasonographic scans of the biceps/brachialis group  (A-B), forearm flexor group (C- 4 
D), quadriceps (E-F), and tibialis anterior (G-H). The left panel depicts muscle thickness 5 
measured through electronic calipers in healthy subjects and the right panel represents 6 
the region of interest for echointensity in subjects with ALS using the ImageJ (v.1.48) 7 
software. 8 
Figure 2. Comparison of quantitative muscular US parameters in controls and ALS patients. 9 
Mean and 95% confidence interval for BBr (biceps/brachialis group), FFG (forearm flexors 10 
group), QF (quadriceps femoris) and TB (tibialis anterior). * p<0.005; **p≤0.001. n.s=non-11 
significative. 12 
  13 
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Table 1. Baseline characteristics of the study sample. 1 
Baseline characteristics ALS Patients (n=26) Healthy (n=26) p-value 
Females (n) (%) 8 (30.8 %) 17 (65.4 %) <0.001 
Age (years) 58.9 (12.02); 55.8 to 62.0 59.6 (6.41); 57.9 to 61.4 0.570 
Weight (kg) 69.9 (17.42); 65.4 to 74.4 72.4 (17.19); 67.6 to 77.2 0.154 
Height (m) 1.67 (0.086); 1.65 to 1.69 1.66 (0.08); 1.63 to 1.68 0.773 
BMI (kg/m
2
) 24.9 (5.13); 23.6 to 26.3 26.2 (4.87); 24.9 to 27.6 0.050 
Time from symptoms onset (months) 26.1 (15.77); 21.72 to 30.5 
 
Symptoms onset-diagnosis (months) 16.3 (9.89); 13.5 to 19.1 
  
Disease onset (n) (%) 
   
Right Lower Limb 9 (34.6 %) 
  
Left Lower Limb 5 (19.2 %) 
  
Right Upper Limb 1 (3.8 %) 
  
Left Upper Limb 4 (15.4 %) 
  
Bulbar 7 (26.9 %) 
  
ALSFRS-r (max 48) 26.2 (11.67); 22.9 to 29.4 
  
MRC (max 100) 58.5 (24.75); 51.7 to 65.4     
Data are presented as mean (Standard deviation) and 95% of confidence interval for quantitative variables and as 2 
absolute frequencies (relative frequencies). BMI: Body Mass Index. ALSFRS-r: Amyotrophic lateral sclerosis 3 
functional rating scale. MRC: Medical Research Council Scale for muscular Strength. P-value for Chi-square 4 
test for sex differences and T-Student test for independent samples for age, weight, height and body mass index 5 
differences.  6 
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Table 2. Quantitative muscular differences between controls and ALS patients. 1 
QMUS 
parameters 
Patients (n=52) Controls  (n=52) 
p-value 
Size 
effect Mean (SD) 95% C.I. Mean (SD) 95% C.I. 
Biceps/brachialis group ‡ 
Thickness 28.6 (6.34) 26.8 to 30.3 32.8 (6.25) 31.1 to 34.6 <0.001 0.90 
Echointensity 92.2 (14.4) 88.2 to 96.2 86.7 (8.78) 84.2 to 89.1 0.001 0.67 
Echovariation 23 (7.33) 21 to 25 29.2 (4.24) 28 to 30.4 <0.001 1.08 
Forearm flexor group ‡‡ 
Thickness 30 (9.69) 27.3 to 32.7 31.3 (5.96) 29.7 to 33 0.016 0.42 
Echointensity 101.4 (15.25) 97.2 to 105.7 90.7 (15.07) 86.5 to 94.9 <0.001 0.88 
Echovariation 19.3 (4.55) 18.1 to 20.6 25.5 (4.22) 24.4 to 26.7 <0.001 1.09 
Quadriceps femoris § 
Thickness 22.9 (8.97) 20.4 to 25.4 29.4 (6.06) 27.7 to 31.1 <0.001 1.00 
Echointensity 100.6 (18.03) 95.5 to 105.6 97 (12.77) 93.4 to 100.5 0.245 0.23 
Echovariation 18.9 (4.46) 17.6 to 20.1 21.7 (5.66) 20.2 to 23.3 0.005 0.55 
Tibialis anterior §§ 
Thickness 19.1 (5.59) 17.5 to 20.6 21.7 (4.91) 20.3 to 23 <0.001 0.91 
Echointensity 116 (16.36) 111.5 to 120.6 105.1 (14.63) 101.1 to 109.2 <0.001 1.03 
Echovariation 16.5 (4.31) 15.3 to 17.7 25 (4.85) 23.6 to 26.3 <0.001 1.35 
SD: Standard Deviation. CI 95%.: Confidence Interval. p-value for independent-samples T-Student test. ‡ 2 
Thickness ANCOVA corrected by sex and BMI, Echointensity and Echovariation corrected for sex. ‡‡ 3 
Thickness ANCOVA corrected for sex and BMI, Echointensity corrected for sex and Echovariation 4 
corrected for BMI. § Thickness ANCOVA corrected for sex. §§ Thickness and Echointensity ANCOVA 5 
corrected for sex. † Effect size was estimated with Cohen’s d (low<0.2; moderate=0.5; large>0.80). 6 
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Table 3. Relation between QMUS parameters and time from symptoms onset. 1 
 Raw Adjusted 
QMUS B coefficient (SE) 95% CI for B p-value Rp (Rp-squared %)* B coefficient (SE) 95% CI for B p-value Rp (Rp-squared %) 
Biceps/brachialis group 
Thickness -0.045 (0.057) -0.16 to 0.070 0.431 -0.112 (1.25%) -0.007 (0.047) -0.10 to 0.09 0.881 -0.022 (0.05%) 
Echointensity -0.050 (0.129) -0.31 to 0.21 0.702 -0.054 (0.29%) -0.133 (0.118) -0.37 to 0.10 0.263 -0.161 (2.6%) 
Echovariation -0.12 (0.064) -0.25 to 0.010 0.064 -0.259 (6.71%) -- -- -- -- 
Forearm flexor group 
Thickness -0.146 (0.084) -0.315 to 0.02 0.091 -0.237 (5.61%) -0.115 (0.072) -0.26 to 0.03 0.116 -0.225 (5.08%) 
Echointensity -0.139 (0.135) -0.411 to 0.13 0.308 -0.144 (2.07%) -0.183 (0.133) -0.45 to 0.08 0.175 -0.193 (3.73%) 
Echovariation -0.002 (0.041) -0.084 to 0.08 0.954 -0.008 (0.01%) -- -- -- -- 
Quadriceps femoris         
Thickness -0.052 (0.08) -0.213 to 0.11 0.519 -0.092 (0.84%) -0.015 (0.075) -0.17 to 0.14 0.844 -0.028 (0.08%) 
Echointensity -0.218 (0.159) -0.536 to 0.1 0.177 -0.19 (3.62%) -- -- -- -- 
Echovariation 0.003 (0.04) -0.165 to 0.14 0.949 0.009 (0.01%) -- -- -- -- 
Tibialis anterior         
Thickness 0.01 (0.05) -0.091 to 0.11 0.841 0.029 (0.08%) 0.042 (0.042) -0.04 to 0.13 0.319 0.142 (2.02%) 
Echointensity 0.004 (0.147) -0.291 to 0.3 0.980 0.004 (0%) -0.089 (0.125) -0.34 to 0.16 0.480 -0.101 (1.02%) 
Echovariation 0.011 (0.039) -0.066 to 0.09 0.771 0.041 (0.17%) -- -- -- -- 
The regression models for thickness were adjusted for sex in biceps/brachialis group, quadriceps femoris, and tibialis anterior and for sex and BMI in forearm flexors. The 2 
regression models for echointensity were adjusted for sex and BMI in biceps/brachialis group, and for sex in forearm flexors and tibialis anterior. The regression models for 3 
echovariation did not need corrections. SE: Standard Error for coefficient B. 95% CI: 95% Confidence Interval. *Rp: partial correlation coefficient and partial 4 
determination coefficient in brackets. Notice that in these analyses, the independent variable was the time from symptoms onset, and the dependent variables were QMUS 5 
parameters. 6 
 
Table 4. Relations between QMUS parameters and MRC score. 1 
QMUS-MRC 
Raw Adjusted 
B coefficient (SE) 95% CI for B p-value Rp (Rp-squared %)* B coefficient (SE) 95% CI for B p-value Rp (Rp-squared %) 
 Biceps/brachialis group (Model Goodness= 58.3%) 
Thickness 1.38 (0.338)      0.71 to 2.05 <0.001 0.378 (14.3%) 1.98 (0.347) 1.29 to 2.67 <0.001 0.498 (24.8%) 
Echointensity -0.32 (0.186) -0.69 to 0.05 0.087 -0.17 (2.9%) -0.34 (0.173) -0.68 to 0 0.053 -0.193 (3.7%) 
Echovariation 1.67 (0.317) 1.04 to 2.3 <0.001 0.466 (21.8%) 1.51 (0.297) 0.92 to 2.1 <0.001 0.454 (20.6%) 
Forearm flexor group (Model Goodness= 48.8%) 
Thickness 0.92 (0.278) 0.37 to 1.47 0.001 0.315 (9.9%) -- -- -- -- 
Echointensity -0.25 (0.145) -0.54 to 0.04 0.087 -0.17 (3.7%) -- -- -- -- 
Echovariation 2.65 (0.383) 1.89 to 3.41 <0.001 0.569 (32.4%) -- -- -- -- 
Quadriceps femoris (Model Goodness= 31.2%) 
Thickness 1.59 (0.295) 1 to 2.17 <0.001 0.475 (22.5%) -- -- -- -- 
Echointensity -0.13 (0.166) -0.46 to 0.2 0.451 -0.075 (0.6%) -- -- -- -- 
Echovariation 0.95 (0.466) 0.03 to 1.87 0.044 0.2 (4.0%) -- -- -- -- 
Tibialis anterior (Model Goodness= 54.9%) 
Thickness 1.15 (0.408) 0.34 to 1.96 0.006 0.272 (7.4%) -- -- -- -- 
Echointensity -0.17 (0.132) -0.43 to 0.09 0.201 -0.128 (1.6%) -- -- -- -- 
Echovariation 2.49 (0.321) 1.85 to 3.12 <0.001 0.612 (37.5%) -- -- -- -- 
The regression models were adjusted for sex in biceps/brachialis group. SE: Standard Error for coefficient B. 95% CI: 95% Confidence Interval. *Rp: partial 2 
correlation coefficient and partial determination coefficient (Rp-squared) in brackets.  The independent variables were the QMUS parameters and the dependent 3 
variable was MRC score. 4 
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B coefficient (SE) 95% CI for B p-value Rp (Rp-squared %)* B coefficient (SE) 95% CI for B p-value Rp (Rp-squared %) 
 Biceps/brachialis group (Model Goodness= 54.9%) 
Thickness 0.69 (0.169)     0.35 to 1.02 <0.001 0.375 (14.1%) 1.03 (0.17)        0.69 to 1.36 <0.001 0.519 (26.9%) 
Echointensity -0.1 (0.093) -0.29 to 0.08 0.270 -0.11 (1.2%) -0.11 (0.085) -0.28 to 0.05 0.183 -0.134 (1.8%) 
Echovariation 0.94 (0.159) 0.63 to 1.26 <0.001 0.51 (26%) 0.85 (0.146) 0.56 to 1.14 <0.001 0.506 (25.6%) 
Forearm flexor group (Model Goodness= 46.1%) 
Thickness 0.39 (0.138) 0.12 to 0.67 0.005 0.275 (7.5%) -- -- -- -- 
Echointensity -0.12 (0.072) -0.26 to 0.02 0.104 -0.162 (2.6%) -- -- -- -- 
Echovariation 1.45 (0.19) 1.07 to 1.83 <0.001 0.606 (36.7%) -- -- -- -- 
Quadriceps femoris (Model Goodness= 29.9%) 
Thickness 0.73 (0.149) 0.44 to 1.03 <0.001 0.441 (19.4%) 0.68 (0.151) 0.38 to 0.98 <0.001 0.414 (17.2%) 
Echointensity -0.1 (0.084) -0.26 to 0.07 0.250 -0.115 (1.3%) -0.12 (0.082) -0.28 to 0.05 0.156 -0.143 (2%) 
Echovariation 0.67 (0.235) 0.2 to 1.13 0.006 0.273 (7.4%) 0.71 (0.228) 0.25 to 1.16 0.003 0.299 (8.9%) 
Tibialis anterior (Model Goodness= 57.4%) 
Thickness 0.56 (0.205) 0.15 to 0.96 0.008 0.263 (6.9%) 0.82 (0.219) 0.39 to 1.26 <0.001 0.355 (12.6%) 
Echointensity -0.13 (0.066) -0.27 to 0 0.045 -0.199 (4.0%) -0.16 (0.065) -0.29 to -0.03 0.014 -0.246 (6%) 
Echovariation 1.2 (0.161) 0.88 to 1.52 <0.001 0.598 (35.8%) 0.98 (0.167) 0.65 to 1.31 <0.001 0.509 (25.9%) 
The regression models ALSFRS-r were adjusted for sex in biceps/brachialis group, for sex and BMI in quadriceps femoris and tibialis anterior. SE: Standard Error for 3 
coefficient B. 95% CI: 95% Confidence Interval. *Rp: partial correlation coefficient and partial determination coefficient (Rp-squared) in brackets. The independent 4 
variables were the QMUS parameters and the dependent variable was ALSFRS-r score 5 
Figure 1
Click here to download high resolution image
Figure 2
Click here to download high resolution image
